Tap any paragraph to write a margin note. Your notes collect in the Desk below the text and file under cases with @. The side-by-side margin rail opens on a larger screen.

Code · REGISTER · 2005-04-13 · Food and Drug Administration, HHS · Notices

Notices. Notice

296 words·~1 min read·/register/2005/04/13/05-7338·

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

BILLING CODE 4184-01-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. 2005N-0059] Withdrawal of Approval of a New Animal Drug Application; Dichlorophene and Toluene Capsules AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration
(FDA)is withdrawing approval of a new animal drug application
(NADA)for dichlorophene and toluene capsules used in dogs and cats for removal of certain intestinal parasites. In a final rule published elsewhere in this issue of the **Federal Register** , FDA is amending the animal drug regulations to remove portions reflecting approval of this NADA. DATES: Withdrawal of approval is effective April 25, 2005. FOR FURTHER INFORMATION CONTACT: Pamela K. Esposito, Center for Veterinary Medicine (HFV-212), Food and Drug Administration, 7519 Standish Pl., Rockville, MD 20855, 301-827-7818, e-mail: *pesposit@cvm.fda.gov* . SUPPLEMENTARY INFORMATION: Natchez Animal Supply Co., 201 John R. Junkin Dr., Natchez, MS 39120, has requested that FDA withdraw approval of NADA 121-557 for THR Worm (dichlorophene and toluene) Capsules used in dogs and cats for removal of certain intestinal parasites. This action is requested because the product is no longer manufactured or marketed. Therefore, under authority delegated to the Commissioner of Food and Drugs (21 CFR 5.10), redelegated to the Center for Veterinary Medicine (21 CFR 5.84), and in accordance with 21 CFR 514.115 *Withdrawal of approval of applications* , notice is given that approval of NADA 121-557 and all supplements and amendments thereto, is hereby withdrawn, effective April 25, 2005. In a final rule published elsewhere in this issue of the **Federal Register** , FDA is amending the animal drug regulations to reflect the withdrawal of approval of this NADA. Dated: March 31, 2005. Catherine P. Beck, Acting Director, Center for Veterinary Medicine. [FR Doc. 05-7338 Filed 4-12-05; 8:45 am]
Connectionstraces to 1
2 references not yet in our index
  • 21 CFR 5.10
  • 21 CFR 5.84
Citation graph
cites case law
Notices
Notice
Cite21 CFR 5.10
Cite21 CFR 5.84
Cites 3Cited by 0 across 0 sources
★   the supreme law of the land   ★
Don't Tread on Me
E Pluribus Unum — out of many, one

"If you don't know your rights, you don't have any."

Marginalia · a citizen's law index
A research desk, not legal advice. Always read the cited source before relying on a summary.
Questions or an issue? support@self-law.org
disclaimerMarginalia is a research index, not a law firm. Nothing on this site is legal, tax, or financial advice and no attorney–client relationship is formed by using it. Statutes, regulations, and case law change; summaries, search results, AI output, and member posts may be incomplete, out of date, or wrong. Any interpretation drawn from material on this site should be validated by a licensed attorney in your jurisdiction before you act on it.